Format

Send to

Choose Destination
Fertil Steril. 2006 Sep;86(3):742-4. Epub 2006 Jun 19.

The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis.

Author information

1
Department of Obstetrics and Gynecology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil. anasars@convex.com.br

Abstract

This study compared the long-term effects of the levonorgestrel-releasing intrauterine device with those of GnRH agonist administration on serum levels of CA-125 in patients with endometriosis. The levonorgestrel-releasing intrauterine device was found to be as efficient as GnRH agonist in reducing CA-125 serum levels.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center